CFO of Ocular Therapeutix Buys 33,000 Stock Options, Signaling Strong Insider Confidence in the Company’s Future
Ocular Therapeutix CFO’s 33,000‑option purchase shows insider confidence and signals potential upside, boosting investor sentiment despite a muted market move.
3 minutes to read